Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The National Institute for Health Research (NIHR) Oxford Biomedical Research (BRC) is holding a series of free events including talks, tours and exhibitions, on the latest advances in research to improve healthcare.

The BRC brings together researchers and clinicians from Oxford University Hospitals NHS Trust and Oxford University to improve healthcare through translational research - taking laboratory research into a clinical setting.  

From 6- 21 March, the BRC ‘Open Weeks’ will showcase some of this world-leading research. This ties in with the Oxfordshire Science Festival and British Science Week.

Events are taking place at a host of venues including the Oxford Natural History Museum and Oxford’s hospitals. All events are free and open to all.

Highlights include a behind–the-scenes look at state-of-the-art scanning facilities.

There will be talks on the latest research into the heart, cancer, blood, genomic medicine and more, as well as interactive exhibitions explaining how technology is revolutionising healthcare in hospital and at home. Vasiliki Kiparoglou, Head of Operations, NIHR Oxford BRC, said:“Oxford  has long been at the forefront of medical research, whether it is the genetic and molecular basis of disease, the latest advances in neuroscience, or clinical studies in cancer, diabetes, heart disease, stroke and other conditions. This is a fantastic opportunity to learn about the benefits to patients of the latest developments in healthcare research.”

More information on the Oxford BRC Open Weeks

 

Similar stories

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.